Lofexidine for Opiate Withdrawal - 1

Completed · Phase 3

Conditions studied: Opioid-Related Disorders

In brief

The purpose of this study is to evaluate lofexidine for opiate withdrawal.

Key facts

Study ID

NCT00032942

Run by

National Institute on Drug Abuse (NIDA)

People needed

66

Starts

2001-04-01

Last updated by the study team

2017-01-12

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female as least 18 yrs of age \& above with a current dependence on heroin, morphine or hydromorphone according to DSM4 criteria; subject ; voluntarily given consent and signed informed consent; females using appropriate birth control method.

You may not qualify if…

• Additional criteria available during screening at the site

Where it is running

• UCLA Medical Center — Los Angeles, California, United States
• Columbia University — New York, New York, United States
• Philadelphia Veterans Medical Center — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.